Genetic disruption of Stat5 activity in a mouse model for liver fibrosis was associated with elevated TGF-β levels and enhanced growth hormone-induced Stat3 activity, ultimately contributing to the development of chronic liver disease (Hosui et al, 2009). This evidence concerns the gene GH1 and Hepatic fibrosis.